Proceeding contribution from Brian Iddon (Labour) in the House of Commons on Monday, 19 May 2008. It occurred during Debate on bill and Committee of the Whole House (HC) on Human Fertilisation and Embryology Bill [Lords].
Human Fertilisation and Embryology Bill [Lords]
The regulator has so far allowed such treatment for only aplastic anaemia, Diamond-Blackfan anaemia and beta thalassaemia. The regulator decides which conditions can be treated by the saviour sibling technology, which in turn determines which tissues can be taken. Would the hon. Gentleman agree with that?
Secondary information
- Type
- Proceeding contribution
- Reference
- 476 c96
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Children Clones Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Foetal tissue Medical treatments Relatives Research Stem cells Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:41:15 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474235
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474235
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474235